Welcome to LookChem.com Sign In|Join Free
  • or
HALAZEPAM CIV (200 MG) (AS) is a benzodiazepine derivative that exhibits anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It serves as a precursor to Desmethyldiazepam (D291595) and is considered equal to or more effective than Diazepam (D416855) with a lower frequency of side effects. As a controlled substance, it is marketed under the brand name Paxipam by Schering.

23092-17-3

23092-17-3 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.

23092-17-3 Usage

Uses

Used in Pharmaceutical Industry:
HALAZEPAM CIV (200 MG) (AS) is used as an anxiolytic agent for treating anxiety disorders, providing relief from symptoms associated with anxiety and stress.
HALAZEPAM CIV (200 MG) (AS) is used as an anticonvulsant medication for managing seizures and other convulsive disorders, helping to prevent and control seizure episodes.
HALAZEPAM CIV (200 MG) (AS) is used as a sedative for inducing sleep and promoting relaxation in patients with insomnia or other sleep disorders.
HALAZEPAM CIV (200 MG) (AS) is used as a skeletal muscle relaxant to alleviate muscle spasms, pain, and stiffness, improving mobility and comfort in patients with muscle-related conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 23092-17-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,0,9 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 23092-17:
(7*2)+(6*3)+(5*0)+(4*9)+(3*2)+(2*1)+(1*7)=83
83 % 10 = 3
So 23092-17-3 is a valid CAS Registry Number.
InChI:InChI=1/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2

23092-17-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one

1.2 Other means of identification

Product number -
Other names Halazepam

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23092-17-3 SDS

23092-17-3Downstream Products

23092-17-3Relevant academic research and scientific papers

Process for the preparation of 1,4-benzo-diazepines and 1,4-benzodiazepinones

-

, (2008/06/13)

This invention relates to an improved process for the preparation of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones and 2,3-dihydro-1H-1,4-benzodiazepines by the condensation of a 2-(2-haloacylamido)-benzophenone or a 2-(2-haloethylamino)-benzophenone, respectively, in the presence of hexamethylenetetramine, a water miscible alcohol containing 5 to 50 volume percent water, and an ammonium salt.

Process for the preparation of 1,4-benzodiazepine derivatives

-

, (2008/06/13)

A 1,4-benzodiazepine derivative, or a pharmaceutically acceptable acid salt thereof, of the formula, SPC1 Wherein R1 is hydrogen, halogen, nitro or trifluoromethyl; R2 and R3 are independently hydrogen, halogen, lower alkyl or trifluoromethyl; R4 is lower alkyl, alkenyl, trihaloalkyl, alkoxyalkyl, alkenyloxyalkyl, alkoxyalkoxyalkyl, alkanoyloxyalkyl, cycloalkylalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl or a group of the formula EQU1 in which R6 and R7 are independently lower alkyl, and n is an integer of 1 to 4; and R5 is hydrogen or lower alkyl, is obtained by reacting a benzophenone derivative of the formula, SPC2 Wherein R1, R2, R3 and R4 are as defined above, with a 2-isocyanatoacetyl chloride derivative of the formula EQU2 wherein R5 is as defined above.

1-POLYHALOGENOALKYL-2-OXO-1,3-DIHYDRO-2H-1,4-BENZODIAZEPINES

-

, (2014/02/11)

This invention relates to 2-oxo-1,3-dihydro-2H-1,4-dibenziodiazepines, and the 4-N-oxides thereof, having a polyfluoroalkyl radical attached at the 1-position thereof, to their use as muscle relaxants, as sedatives, an anticonvulsants, and as anti-anxiety agents and to the intermediates useful in the preparation thereof. The compounds may be prepared by N-polyfluoroalkylating the appropriately substituted 2-oxo-1,3-dihydro-2H-1,4-benzodiazepines. Alternate methods for the synthesis of the compounds of this invention are also described